Dr. Linda Liau wants to start another trial with BMY with CSFr-1(?). If they really wanted to claim to be part of a cancer cure they would have paid for that trial start to finish. The problem with combos is the details matter and one of the details is that DCVax is the most important driver towards a cure so why would they want to drive up the stock price by letting the world know about that little detail when they are making so much right now and too much attention to NWBO could draw attention and support away from them? Balancing act. Timing issue. Best wishes.
News 
Market Data 
Discover 
AI
